Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-046-9 | CAS number: 91-17-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Two published and one unpublished microbial mutagenicity assay
demonstrated the lack of mutagenic activity of decahydronaphthalene. In
addition, published in vitro studies on mammalian mutagenicity assay
(mouse lymphoma cells) and chromosomal aberration (Chinese Hamster lung
cells) revealed no genotoxic activity of the test substance.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-09-25 to 1989-10-31
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study with acceptable restrictions: TA 102 or E.coli WP2 were not tested (not required by applied version of guideline).
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- Cited as Directive 84/449/EEC, B.14
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- mutated gene loci responsible for histidine auxotrophy
- Species / strain / cell type:
- S. typhimurium, other: strainsTA 1535, TA 1537, TA 1538, TA 98, TA 100
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254 induced rat S9 liver, male Bor: WISW (SPF/Cpb) rats
- Test concentrations with justification for top dose:
- 8; 40; 200; 1000; 5000 µg/plate
- Vehicle / solvent:
- solvent acetone (CAS No. 67-64-1)
- Untreated negative controls:
- yes
- Remarks:
- untreated
- Negative solvent / vehicle controls:
- yes
- Remarks:
- solvent controls
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- sodium azide
- other: Aminoacridine TA 1537
- Details on test system and experimental conditions:
- Ames test
SYSTEM OF TESTING
- Metabolic activation system: Aroclor 1254 induced rat S9 liver, male Bor: WISW (SPF/Cpb) rats
ADMINISTRATION:
- Dosing:
main test: 8/40/200/1000/5000 µg/plate (+/- metabolic activation)
pre-incubation test: 125/250/500/1000/2000 µg/plate (+/- metabolic activation)
- Number of replicates: 3
- Application:
solvent acetone (CAS No. 67-64-1) main test 100 g/l, pre-incubation test 80 g/l
- Positive and negative control groups and treatment:
positive, TA 98 and TA 1538: nitrofluorene
positive, TA 100 and TA 1535: sodium azide
positive, TA 1537: aminoacridine
negative: untreated + solvent controls
activity of metabolic system: aminoanthracene / TA 100
- Pre-incubation: 30 minutes at 30 °C
incubation 96 hours at 37 °C - Evaluation criteria:
- CRITERIA FOR EVALUATING RESULTS:
mutagenic effects (i.e ratio of revertant rates treated/control >= 2) at <= 5000 µg/plate with generally positive dose-response relationship in
any strain - Statistics:
- no data
- Species / strain:
- S. typhimurium, other: strains TA 1535, TA 1537, TA 1538, TA 98, TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: > 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: other: Salmonella typhimurium TA 1535, TA 1537, TA 1538, TA 98, TA 100
- Conclusions:
- Decahydronaphthalene was not genotoxic in both the presence or absence of metabolic activation in a microbial mutagenicity assay.
- Executive summary:
In a reverse gene mutation assay in bacteria, strains TA98, TA100, TA1535, TA1537 and TA1538 of Salmonella typhimurium were exposed to decahydronaphthalene using acetone as a vehicle at concentrations of 8 - 5000 µg/plate, with and without S-9 activation in a preincubation assay according to EEC guidance Dir. 84/449/EEC, B.14.
The test article was tested at six dose levels along with appropriate vehicle and positive controls on the tester strains mentioned above in the presence and absence of S9-mix. All dose levels, vehicle and positive controls were plated in triplicate.
Cytotoxicity was noted at 1000 -5000 µg/plate.
No positive mutagenic responses were observed with any of the strains used, in the presence as well as in the absence of microsomal enzymes.These results were confirmed in an independent assay.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1993
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: published, peer reviewed study, not guideline mentioned
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- GLP compliance:
- not specified
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- other: Chinese hamster lung cell (CHL/IU)
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat S9 mix
- Test concentrations with justification for top dose:
- continious treatment (24/48 h) without S9: 0.15, 0.30, 0.60 , 1.20 mg/mL
Pulse treatment (6h) with S9: 0.63, 1.25, 2.50, 5.00 mg/mL - Vehicle / solvent:
- Ethanol
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Mitomycin (without S9), Cyclophosphamide (with S9)
- Details on test system and experimental conditions:
- no data
- Statistics:
- no data
- Species / strain:
- other: Chinese hamster lung cells (CHL/IU)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5.0 mg/L without S9
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- negative;
No increase in chromosomal aberrations was observed both with and without metabolic activation. - Executive summary:
A chromosome aberration test was conducted with Chinese hamster CHL/IU cells to investigate whether decahydronaphthalene induces structural or numerical aberrations. The test was conducted with or without metabolic activation system (rat S9-mix). Results indicated that decalin induces no chromosomal aberrations, both structurally and numerically under the present experimental conditions
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991-04-22 to 1991-08-23
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- thymidine kinase locus in mouse lymphoma cells
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S9 mix
- Test concentrations with justification for top dose:
- 50-450 mg/l (+ S9); 5-45 mg/l + 9-100 mg/l (- S9)
- Vehicle / solvent:
- Application: solvent ethanol
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- ethanol
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- 3-methylcholanthrene with S9
Migrated to IUCLID6: without S9 - Details on test system and experimental conditions:
- Mouse lymphoma assay
- Metabolic activation system: Aroclor 1254-induced rat liver S9 mix
ADMINISTRATION:
- Dosing: Initial toxicity test (1 replicate): 0.5; 1; 5; 10; 50; 100; 500; 1000; 5000 mg/l (+/- S9) Main studies, selected for cloning: 250; 300; 350; 400; 450 mg/l (+ S9) 25; 30; 35; 40; 45 mg/l (- S9) 9; 22; 35; 48; 61 mg/l (- S9)
- Number of replicates: 2
- Application: solvent ethanol
- Positive and negative control groups and treatment:
positive (+ S9): 3-methylcholanthrene, solvent DMSO
positive (- S9): ethylmethanesulfonate, solvent DMSO
negative (+/- S9): 2 untreated + 4 solvent replicates
- Pre-incubation time: two-day expression period
DESCRIPTION OF FOLLOW UP REPEAT STUDY: see second concentration series - S9 - Evaluation criteria:
- CRITERIA FOR EVALUATING RESULTS: dose-dependent increase in mutant frequency
- Statistics:
- no data
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- other: >= 300 mg/l (+ S9); >= 48 mg/l (- S9)
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- GENOTOXIC EFFECTS:
- With metabolic activation: none
- Without metabolic activation: none
The positive controls were all as expected.
CYTOTOXIC CONCENTRATION:
- With metabolic activation: Initial toxicity test: >= 500 mg/l Main test: >= 300 mg/l
- Without metabolic activation: Initial toxicity test: >= 50 mg/l
Main test: No significant cytotoxicity
Follow-up: >= 48 mg/l - Remarks on result:
- other: L5178Y TK+/-
- Conclusions:
- negative; Decahydronaphthalene was not genotoxic.
- Executive summary:
No induction of micronuclei in peripheral blood NCEs was observed in female mice exposed to 25 to 400 ppm decalin for 3 months by inhalation. In contrast to the negative results in females, a small but statistically significant increase in the frequency of micronucleated NCEs was noted in peripheral blood of male mice. A slight increase over the exposure range in the percentage of PCEs was seen in males and females; all values, however, were within the normal range.
Referenceopen allclose all
GENOTOXIC EFFECTS:
- With metabolic activation: None
- Without metabolic activation: Slight effects in TA 98 and TA 1537 in the main test and slight effects in TA 1537 in the pre-incubation test were associated with very low revertant rates in solvent control and not dose-related.
Thus they were not considered to be signs of mutagenicity:
-------------------------------------------------------
Revertant rates in pre-incubation test without metabolic activation:
TA 1537, untreated: 8; solvent: 7; 125 µg: 7; 250 µg: 9; 500 µg: 7; 1000 µg: 15; 2000 µg: 15
-------------------------------------------------------
Revertant rates in main test without metabolic activation:
TA 98, untreated: 11; solvent: 4; 8 µg: 4; 40 µg: 10; 200 µg: 4; 1000 µg: 5; 5000 µg: 15, precipitation
TA 1537, untreated: 7; solvent: 4; 8 µg: 7; 40 µg: 4; 200 µg: 12; 1000 µg: 3; 5000 µg: 0, toxic and precipitation
-------------------------------------------------------
The positive controls were functional.
PRECIPITATION CONCENTRATION: 5000 µg/plate
CYTOTOXIC CONCENTRATION:
TA 98: None (+/- S9)
TA 100: None (+/- S9)
TA 1535: 5000 µg/plate (+/- S9)
TA 1537: 5000 µg/plate (- S9)
TA 1538: None (+/- S9)
Chromosomal aberration test without metabolic activation (continuous treatment 24/48h)
|
Concentration (mg/mL) |
Treatment time |
|||
24 h |
48h |
||||
Percentage of cells showing structural aberrations |
|||||
-gaps |
+gaps |
-gaps |
+gaps |
||
Solvent (Ethanol) |
10 µl/mL |
4.0 |
4.5 |
2.5 |
2.5 |
Decahydronaphthalene |
0.15 |
0.5 |
0.5 |
0 |
0 |
0.30 |
2.0 |
2.0 |
2.0 |
2.5 |
|
0.60 |
2.4 |
2.4 |
2.0 |
2.0 |
|
1.20 |
1.0 |
1.5 |
1.0 |
1.0 |
|
Positive control Mitomycin |
0.02 |
28.5 |
29.5 |
37.5 |
38.0 |
Chromosomal aberration test without and with metabolic activation (6h treatment)
|
Concentration (mg/mL) |
Metabolic activation |
|||
Without S9mix |
With S9mix |
||||
Percentage of cells showing structural aberrations |
|||||
-gaps |
+gaps |
-gaps |
+gaps |
||
Solvent (1% CMC) |
0.1 µl/mL |
2.0 |
2.0 |
1.5 |
1.5 |
Decahydronaphthalene |
0.63 |
2.5 |
2.5 |
2.5 |
2.5 |
1.25 |
3.0 |
3.5 |
1.5 |
1.0 |
|
2.5 |
1.0 |
1.0 |
1.0 |
1.0 |
|
5.0 |
Toxic |
1.0 |
1.0 |
||
Positive control Cyclophosphamide |
10.0 |
3.5 |
5.0 |
25.0 |
25.5 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
A mouse micronucleus assay following 3 months inhalation showed no clastogenic activity in female but a slight clastogenic activity in male mice was noted. No clastogenic effect was noted in dogs following 3 months inhalation.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996-09-16 to 1996-12-20
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Comparable to Guideline study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- subchronic exposure
- Principles of method if other than guideline:
- NTP mouse peripheral blood micronucleus test protocol
MacGregor, J. T., Wehr, C. M., Henika, P. R., Shelby, M. D.(1990) Fund. Appl. Toxicol. 14, 513. - GLP compliance:
- yes
- Type of assay:
- micronucleus assay
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ORGANISMS:
- Source: Taconic Laboratory Animals and Services, Germantown (NY, USA)
- Age: 6 weeks at study initiation
- Weight at study initiation: males mean 21.9 g, females mean 19.6 g
- Number of animals: 10 males + 10 females per exposure concentration - Route of administration:
- inhalation: vapour
- Vehicle:
- Vehicle: clean air
- Details on exposure:
- ADMINISTRATION:
- Concentration in vehicle: established within 12 minutes, monitored every 24 minutes At 72 +- 3 °F (22.2 °C) the ppm concentrations
correspond to: 143, 285, 570, 1141, 2282 mg/m3
- Frequency of treatment: 6 hours (+ 12 minutes concentration buildup)/day, 5 days/week
- Control groups and treatment: concurrent vehicle
EXAMINATIONS:
CLINICAL OBSERVATIONS AND FREQUENCY:
- Clinical signs: observed twice daily
- Mortality: observed twice daily
- Clinical findings: weekly
- Body weight: initially + weekly + end of study
- Hematology: Blood sampling at end of study. Determination of hematocrit; packed red cell volume; hemoglobin; erthrocyte, reticulocyte, nucleated erythrocyte, and platelet counts; mean cell volume; mean cell hemoglobin; mean cell hemoglobin concentration; and leukocyte count and
differentials.
- Biochemistry: None
- Urinalysis: Sampling during week 12. Determination of creatinine, glucose, glucose/creatinine ratio, protein, protein/creatinine ratio, alkaline
phosphatase, alkaline phosphatase/creatinine ratio, alkaline aminotransferase, aspartate aminotransferase, aspartate aminotransferase/creatinine ratio, lactate dehydrogenase, lactate dehydrogenase/creatinine ratio, gamma-glutamyltransferase, gamma-glutamyltransferase/creatinine ratio, N-acetyl-beta-D-glucosaminidase, N-acetyl-beta- D-glucosaminidase/creatinine ratio, volume, and specific gravity.
ORGANS EXAMINED AT NECROPSY (MACROSCOPIC AND MICROSCOPIC):
- Weights: heart, right kidney, liver, lung, right testis, thymus
- Macroscopic: yes, no details reported
- Microscopic: 0 and 400 ppm animals: gross lesions, adrenal gland, bone with marrow, brain, clitoral gland, esophagus, gall bladder, heart, large
intestine (cecum, colon, rectum), small intestine (duodenum, jejunum, ileum), kidney, larynx, liver, lung, lymph nodes (mandibular, mesenteric,
bronchial, and mediastinal), mammary gland (females only), nose, ovary, pancreas, parathyroid gland, pituitary gland, preputial gland, prostate
gland, salivary gland, skin, spleen, stomach (forestomach and glandular), testis with epididymis and seminal vesicle, thymus, thyroid gland,
trachea, urinary bladder, and uterus.
- Sampling times and number of samples: end of 3-month toxicity study, peripheral blood samples 2000 NCEs (normochromatic erythrocytes)
per animal were analysed for micronuclei in up to 10 animals per exposure group. 1000 erythrocytes were counted to determine the percentage
of polychromatic (immature) erythrocytes (PCEs) among the total erythrocyte population.
- Criteria for evaluating results:
(1) one-tailed Cochran-Armitage trend test, followed by pairwise comparisons between each exposed group and the control, for determination
of concentration-response relationship
(2) adjustment in case of excess binomial variation (binomial dispersion test)
(3a) P <= 0.025 in trend test OR
(3b) single group with P <= 0.025/number of exposed groups
(4) expert judgment by scientific staff
- Criteria for selection of M.T.D.: Low mortality and low impairment of body weight development in preceding two-week study - Duration of treatment / exposure:
- 14 weeks; 1 additional day before end of study
- Frequency of treatment:
- 6 hours (+ 12 minutes concentration buildup)/day, 5 days/week
- Post exposure period:
- Post-exposure period: none
- Remarks:
- Doses / Concentrations:
25, 50, 100, 200, 400 ppm
Basis:
analytical conc. - No. of animals per sex per dose:
- 10
- Control animals:
- yes, sham-exposed
- Evaluation criteria:
- In the micronucleus test, an individual trial is considered positive if the trend test P value is less than or equal to 0.025 or
if the P value for any single exposed group is less than or equal to 0.025 divided by the number of exposed groups.
A final call of positive for micronucleus induction is preferably based on reproducibly positive trials. - Statistics:
- The frequency of micronucleated cells among NCEs was analyzed by a statistical software package that tested for increasing trend over exposure groups with a one-tailed Cochran- Armitage trend test, followed by pairwise comparisons between each exposed group and the chamber control group
(ILS, 1990). In the presence of excess binomial variation, as detected by a binomial dispersion test, the binomial variance of the Cochran-Armitage test was adjusted upward in proportion to the excess variation. - Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- not applicable
- Additional information on results:
- MORTALITY: All mice survived to the end of the study.
CLINICAL SIGNS: There were no clinical findings related to exposure.
NECROPSY FINDINGS: see subchronic toxicity study
BODY WEIGHT CHANGES: see subchronic toxicity study
GENOTOXIC EFFECTS:
- males: small but statistically significant (P=0.001) increase in frequency of micronucleated NCEs with exposure concentration
- female: no induction of micronuclei (P=0.917)
- both: slight increase over exposure range in percentage of PCEs, however, all values were within the normal range
NOAEL (NOEL) (C) / LOAEL (LOEL) (C): see subchronic toxicity study - Conclusions:
- No effects were noted in females, a slight statistically significant increase in micronucleated normochromatic erythrocytes was observed in males but the values were within the normal range.
- Executive summary:
As part of the repeated dose study, following inhalation exposure to decahydronaphthalene for 5 days per week, 4 hours per day for a period of 3 months blood smears from 10 male and ten female mice were obtained. Dose levels were 0, 25, 50, 100, 200, 400. A slight but statistically significant increase in micronucleated normochromatic erythrocytes was observed in males ppm. However the values were within the normal range. No effects were noted in female mice.
Reference
EFFECT ON MITOTIC INDEX OR PCE/NCE RATIO:
--------------------------------------------------------
Treatment Mice scored Sex % Micron. in PCE PCEs (%)
--------------------------------------------------------
0 ppm 10 m 5.5 +/- 1.6 1.8
25 ppm 10 m 4.5 +/- 1.6 1.8
50 ppm 10 m 10.0 +/- 1.5 2.0
100 ppm 10 m 10.0 +/- 2.2 1.9
200 ppm 10 m 12.5 +/- 2.0 1.9
400 ppm 9 m 13.3 +/- 2.0 2.6
--------------------------------------------------------
0 ppm 9 f 6.7 +/- 2.0 1.6
25 ppm 10 f 5.0 +/- 1.1 1.8
50 ppm 10 f 7.0 +/- 1.9 1.6
100 ppm 10 f 3.5 +/- 1.3 1.5
200 ppm 10 f 3.0 +/- 0.8 2.0
400 ppm 10 f 4.0 +/- 1.2 2.0
--------------------------------------------------------
GENOTOXIC EFFECTS:
- males: small but statistically significant (P=0.001) increase in frequency of micronucleated NCEs with exposure concentration
- female: no induction of micronuclei (P=0.917)
- both: slight increase over exposure range in percentage of PCEs, however, all values were within the normal range
NOAEL (NOEL) (C) / LOAEL (LOEL) (C): see subchronic toxicity study
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
No genotoxic activity was noted in an array of in vitro tests. In vivo following three months inhalation exposure no clastogenicity was noted in male and female dogs or female mice while a statistically significant effect was noted in male mice. However, since the observed effect was very small, and no increased incidence of neoplastic effects were noted in male mice in the NTP 2-year study this is considered to be toxicologically irrelevant.
Justification for classification or non-classification
The in vitro genotoxicity studies with decahydronaphthalene revealed clearly negative results. The data base on investigations of clastogenic effects indicates that the test substance has only a weak genotoxic potential in vivo in male mice and therefore must not be classified according to CLP Regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.